HOFBF
Price
$0.17
Change
+$0.01 (+6.25%)
Updated
Jul 7 closing price
Capitalization
76.32M
INNMF
Price
$0.21
Change
-$0.01 (-4.55%)
Updated
Jul 17 closing price
Capitalization
68.4M
Interact to see
Advertisement

HOFBF vs INNMF

Header iconHOFBF vs INNMF Comparison
Open Charts HOFBF vs INNMFBanner chart's image
Hofseth Biocare ASA
Price$0.17
Change+$0.01 (+6.25%)
Volume$10K
Capitalization76.32M
Amplia Therapeutics
Price$0.21
Change-$0.01 (-4.55%)
Volume$68.66K
Capitalization68.4M
HOFBF vs INNMF Comparison Chart in %
Loading...
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOFBF vs. INNMF commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOFBF is a Hold and INNMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (HOFBF: $0.17 vs. INNMF: $0.21)
Brand notoriety: HOFBF and INNMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOFBF: 431% vs. INNMF: 127%
Market capitalization -- HOFBF: $76.32M vs. INNMF: $68.4M
HOFBF [@Biotechnology] is valued at $76.32M. INNMF’s [@Biotechnology] market capitalization is $68.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOFBF’s FA Score shows that 0 FA rating(s) are green whileINNMF’s FA Score has 0 green FA rating(s).

  • HOFBF’s FA Score: 0 green, 5 red.
  • INNMF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than HOFBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOFBF’s TA Score shows that 1 TA indicator(s) are bullish while INNMF’s TA Score has 3 bullish TA indicator(s).

  • HOFBF’s TA Score: 1 bullish, 1 bearish.
  • INNMF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, HOFBF is a better buy in the short-term than INNMF.

Price Growth

HOFBF (@Biotechnology) experienced а 0.00% price change this week, while INNMF (@Biotechnology) price change was -12.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOFBF($76.3M) has a higher market cap than INNMF($68.4M). INNMF YTD gains are higher at: 407.264 vs. HOFBF (66.600). INNMF has higher annual earnings (EBITDA): -6.43M vs. HOFBF (-73.54M). HOFBF has more cash in the bank: 71.9M vs. INNMF (10.9M). INNMF has less debt than HOFBF: INNMF (13.9K) vs HOFBF (236M).
HOFBFINNMFHOFBF / INNMF
Capitalization76.3M68.4M112%
EBITDA-73.54M-6.43M1,144%
Gain YTD66.600407.26416%
P/E RatioN/AN/A-
Revenue266MN/A-
Total Cash71.9M10.9M660%
Total Debt236M13.9K1,697,842%
FUNDAMENTALS RATINGS
HOFBF vs INNMF: Fundamental Ratings
HOFBF
INNMF
OUTLOOK RATING
1..100
3984
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
4334
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INNMF's Valuation (51) in the null industry is somewhat better than the same rating for HOFBF (85). This means that INNMF’s stock grew somewhat faster than HOFBF’s over the last 12 months.

INNMF's Profit vs Risk Rating (62) in the null industry is somewhat better than the same rating for HOFBF (100). This means that INNMF’s stock grew somewhat faster than HOFBF’s over the last 12 months.

INNMF's SMR Rating (97) in the null industry is in the same range as HOFBF (99). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

INNMF's Price Growth Rating (34) in the null industry is in the same range as HOFBF (43). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

INNMF's P/E Growth Rating (100) in the null industry is in the same range as HOFBF (100). This means that INNMF’s stock grew similarly to HOFBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOFBFINNMF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
15%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
14%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
11%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
64%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
68%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
HOFBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CODYY23.350.48
+2.10%
Compagnie de Saint-Gobain
CZBC9.94N/A
N/A
Citizens Bancorp
IPOAF27.00N/A
N/A
Industrias Penoles S.A. de C.V.
JDWPF9.47N/A
N/A
J.D. Wetherspoon PLC
SHMY3.00N/A
N/A
SYNERGY EMPIRE LTD.

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been loosely correlated with BIVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOFBF jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
BIVI - HOFBF
44%
Loosely correlated
+10.12%
ETXPF - HOFBF
38%
Loosely correlated
N/A
PHGE - HOFBF
35%
Loosely correlated
+3.92%
INNMF - HOFBF
23%
Poorly correlated
-4.77%
GOVX - HOFBF
3%
Poorly correlated
-0.53%
More

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
-4.77%
BIVI - INNMF
26%
Poorly correlated
+10.12%
HOFBF - INNMF
23%
Poorly correlated
N/A
CYTK - INNMF
23%
Poorly correlated
+0.54%
PHRRF - INNMF
20%
Poorly correlated
+1.74%
IVEVF - INNMF
15%
Poorly correlated
N/A
More